Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/25539
Title: | Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment | Authors: | Costa, Pedro M. Cardoso, Ana L. Mendonça, Liliana S. Serani, Angelo Custódia, Carlos Conceição, Mariana Simões, Sérgio Moreira, João N. Almeida, Luis Pereira de Lima, M. C. P. de |
Keywords: | chlorotoxin; glioblastoma; liposome; miR-21; stable nucleic acid lipid particle | Issue Date: | 2013 | Publisher: | The American Society of Gene & Cell Therapy | metadata.degois.publication.title: | Molecular Therapy—Nucleic Acids | metadata.degois.publication.volume: | 2 | metadata.degois.publication.issue: | Artigo e100 | Abstract: | The present work aimed at the development and application of a lipid-based nanocarrier for targeted delivery of nucleic acids to glioblastoma (GBM). For this purpose, chlorotoxin (CTX), a peptide reported to bind selectively to glioma cells while showing no affinity for non-neoplastic cells, was covalently coupled to liposomes encapsulating antisense oligonucleotides (asOs) or small interfering RNAs (siRNAs). The resulting targeted nanoparticles, designated CTX-coupled stable nucleic acid lipid particles (SNALPs), exhibited excellent features for in vivo application, namely small size (<180 nm) and neutral surface charge. Cellular association and internalization studies revealed that attachment of CTX onto the liposomal surface enhanced particle internalization into glioma cells, whereas no significant internalization was observed in noncancer cells. Moreover, nanoparticle-mediated miR-21 silencing in U87 human GBM and GL261 mouse glioma cells resulted in increased levels of the tumor suppressors PTEN and PDCD4, caspase 3/7 activation and decreased tumor cell proliferation. Preliminary in vivo studies revealed that CTX enhances particle internalization into established intracranial tumors. Overall, our results indicate that the developed targeted nanoparticles represent a valuable tool for targeted nucleic acid delivery to cancer cells. Combined with a drug-based therapy, nanoparticle-mediated miR-21 silencing constitutes a promising multimodal therapeutic approach towards GBM. | URI: | https://hdl.handle.net/10316/25539 | DOI: | 10.1038/mtna.2013.30 | Rights: | openAccess |
Appears in Collections: | FCTUC Ciências da Vida - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
mtna201330a(1).pdf | 3.99 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
82
checked on Nov 11, 2022
WEB OF SCIENCETM
Citations
1
86
checked on Nov 2, 2024
Page view(s) 50
504
checked on Nov 6, 2024
Download(s) 50
556
checked on Nov 6, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.